Metal-free carbon monoxide prodrugs may help prevent cancer's deadly spread
Researchers at Weill Cornell Medicine have developed a metal-free carbon monoxide prodrug that shows promise in preventing the spread of pancreatic and breast cancer. The compound releases low, controlled doses of carbon monoxide to inhibit metastasis without the toxicity associated with traditional delivery methods.
Why it matters
This innovation could provide a safer, more effective way to prevent cancer recurrence and metastasis in patients who have undergone surgery or chemotherapy.
edited by Lisa Lock , reviewed by Andrew Zinin
The article is a straightforward summary of scientific research published in a peer-reviewed journal.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in